108 MCY-M11, a CAR-PBMC cell product transiently expressing a mesothelin targeted mRNA CAR, exhibits desirable functional and immune phenotype attributed to sustained antitumor immunity in vitro

• Sashi Kasimsetty,
• Himavanth Gatla,
• Dhana Chinnasamy

Affiliations

Sashi Kasimsetty

CARMA Cell Therapies™, Gaithersburg, MD, USA

Himavanth Gatla

CARMA Cell Therapies™, Gaithersburg, MD, USA

Dhana Chinnasamy

CARMA Cell Therapies™, Gaithersburg, MD, USA